BUNKER KEVIN D. (Chief Operating Officer) sold 0.7% of their position (6.07K shares) of ZENTALIS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $118.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 10/6/2023ACC: 0001725160-23-000180
Officer· Chief Operating Officer
Since Apr 2020
-6.07K
Net shares
Net seller
$118.4K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
6.07K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−5.08K
Price / share
$19.43
Trade value
$98.78K
% of position
0.6%
10/4/2023
865.16K→860.07K
Common Stock
Direct
Shares
−983.00
Price / share
$19.91
Trade value
$19.57K
% of position
0.1%
10/4/2023
860.07K→859.09K
Total
Net shares
−6.07K
Net value
-$118.36K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/4/2023 | S · Sale | −5.08K | $19.43 | $98.78K | 0.6% | 865.16K | 860.07K |
| Common Stock Direct | 10/4/2023 | S · Sale | −983.00 | $19.91 | $19.57K | 0.1% | 860.07K | 859.09K |
| Total | −6.07K | -$118.36K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned350.00
Common Stock
IndirectShares owned15K
Total
15.35K indirect15.35K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 350.00 | Indirect |
| Common Stock | 15K | Indirect |
| Total | 15.35K | 15.35K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported